Table 1 Number of significantly regulated peptides and proteins based on a +/− 30% fold-change and p ≤ 0.05 comparing all disease phenotypes.
From: Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis
Differentially-expressed peptides | Differentially-expressed proteins | |
|---|---|---|
PBMC study | ||
B-ALS vs L-ALS | 1,003 | 132 |
B-ALS fast vs B-ALS slow | 230 | 28 |
L-ALS fast vs L-ALS slow | 185 | 20 |
B-ALS fast vs L-ALS fast | 1,039 | 150 |
B-ALS slow vs L-ALS slow | 502 | 88 |
Plasma/brain study | ||
B-ALS vs L-ALS | 2,759 | 554 |
